Topical Delivery of Human Single-Domain Antibodies Targeting IL-33 Shows Potential to Treat Mucosal Inflammation

11·06·2025

World's First HLA-G Targeted Exosome Therapy for Cancer Enters U.S. Clinical Trials

10·06·2025

BioAge Expands Metabolic Disease Pipeline with Nanobody-Based APJ Agonist from JiKang Therapeutics

05·06·2025

Ultrapotent SARS Coronavirus-Neutralizing VHH Antibodies Clamp the Spike at Its Base

04·06·2025

Genetic Engineering of VHH Antibodies Enables Precise Conjugation to Polysaccharides Using Thiol–Maleimide Chemistry

26·05·2025

Thymic Carcinoma Pipeline Shows Strong Momentum With 4+ Pharma Players Advancing Promising Therapeutics

22·05·2025